BioCentury
ARTICLE | Company News

Novartis receives approval, approvable letter

September 22, 2000 7:00 AM UTC

Japan granted marketing approval to Novartis (SWX:NOVN; NVS) for its Diovan valsartan angiotensin receptor blocker to treat hypertension. NOVN plans to launch the product by year end. Also, NOVN recei...